Literature DB >> 28089798

A meta-analysis of external fixation versus open reduction and internal fixation for complex tibial plateau fractures.

Xing-Wen Zhao1, Jian-Xiong Ma2, Xin-Long Ma3, Xuan Jiang4, Yin Wang5, Fei Li6, Bin Lu5.   

Abstract

PURPOSE: Both external fixation (ExFx) and open reduction and internal fixation(ORIF) were used to treat complex tibial plateau fractures, but it was not sure which one was better. So we did this meta-analysis to evaluate the outcomes of ExFx and ORIF in managing complex tibial plateau fractures.
METHODS: Articles published before August 5, 2016 were selected from PubMed, Cochrane library, and some other electronic database. Relevant journals were also searched manually with no language limited. Two independent reviewers searched and assessed the literature. A fixed effect model was initially used for meta-analyses with RevMan 5.3.
RESULTS: When compared with ORIF, cases undergoing ExFx were more likely to return to the preinjury state at the early stage, but no difference in the later period of follow-up. However, ExFx group had higher infection rate (OR 1.98, 95% CI 1.08-3.63, P = 0.03), higher venous thromboembolism rate (OR 1.56, 95% CI 0.49-4.96, P = 0.45), higher re-operation rate (OR 0.87, 95% CI 0.47-1.62, P = 0.66) and lower compartment syndrome rate (OR 0.61, 95% CI 0.12-3.22, P = 0.56), lower TKA rate (OR 0.51, 95% CI 0.20-1.34, P = 0.17). There were no statistically significant differences in the rate of deep infection, venous thromboembolism, compartment syndrome and VTE between the two groups.
CONCLUSION: Although external fixation may offer some advantages, both were acceptable strategies in managing complex tibial plateau fractures. According to our analysis results, we strongly recommend that selection of definitive fixators should base on the fracture patterns, soft-tissue condition as well as the injury stages in clinical practice. More important, further multicentered, randomized controlled studies should be implemented to get a more reliable and clear result.
Copyright © 2017 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complex tibial plateau fractures; External fixation (ExFx); Open reduction and internal fixation (ORIF)

Mesh:

Year:  2017        PMID: 28089798     DOI: 10.1016/j.ijsu.2017.01.044

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  6 in total

1.  Comparison of Postoperative Outcomes Between Open Reduction and Internal Fixation and Ilizarov for Schatzker Type V and Type VI Fractures.

Authors:  Muhammad Tahir; Sandeep Kumar; Saeed A Shaikh; Allah Rakhio Jamali
Journal:  Cureus       Date:  2019-06-14

2.  Comparison between open reduction with internal fixation to circular external fixation for tibial plateau fractures: A systematic review and meta-analysis.

Authors:  Zheng Li; Ping Wang; Li Li; Changshu Li; He Lu; Chuanshuang Ou
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

3.  Ilizarov Fixation Method of Tibia Plateau Fractures: A Prospective Observational Study.

Authors:  Shahzaib R Baloch; Mohammad S Rafi; Javeria Junaid; Mohammad Shah; Faateh Siddiq; Syed Ata-Ur-Rahman; Zardana Zohaib
Journal:  Cureus       Date:  2020-10-31

4.  Ilizarov Ring External Fixation for Complex Tibial Plateau Fractures.

Authors:  Anil Ghimire; Pramod Devkota; Kailash Kumar Bhandari; Yubaraj Kharel; Saju Pradhan
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2021-11-11

Review 5.  A Meta-analysis Comparing External Fixation against Open Reduction and Internal Fixation for the Management of Tibial Plateau Fractures.

Authors:  Ahmad S Naja; Nour Bouji; Mohamad Nasser Eddine; Humaid Alfarii; Rudolf Reindl; Yehia Tfayli; Mohamad Issa; Said Saghieh
Journal:  Strategies Trauma Limb Reconstr       Date:  2022 May-Aug

6.  New Developments in Treatments of Tibial Plateau Fractures.

Authors:  Ya-Ke Liu; Zhen-Yu Zhou; Fan Liu
Journal:  Chin Med J (Engl)       Date:  2017-11-05       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.